Skip to main content
Home / Current Signal Transduction Therapy, Volume 7, Number 3
In recent years a breakthrough has occurred in our understanding of the molecular pathomechanisms of human diseases whereby most of our diseases are related to intra and intercellular communication disorders. The concept of signal transduction therapy has got into the front line of modern drug research, and a multidisciplinary approach is being used to identify and treat signaling disorders.

The aim of this journal is to publish timely in-depth reviews as well as original papers in the field of signal transduction therapy. Thematic issues will also be published to cover selected areas of signal transduction therapy. Coverage of the field will include genomics, proteomics, medicinal chemistry and the relevant diseases involved in signaling e.g. cancer, neurodegenerative and inflammatory diseases.

Current Signal Transduction Therapy is an essential journal for all involved in drug design and discovery.

Publisher: Bentham Science Publishers

More about this publication?
Volume 7, Number 3, 2012

Articles

Open Access EDITORIAL (Hot Topic: “Signal Transduction and Response to Anti-Cancer Therapy”)
pp. 185-186(2)
Author: Skvortsova, Ira-Ida

Favourites:
ADD

Open Access Review: The JAK/STAT Protein Activation – Role in Cancer Development and Targeted Therapy
pp. 187-201(15)
Authors: Domanska, Daria; Brzezianska, Ewa

Favourites:
ADD

Open Access Peripherally Located A431 Cells are More Sensitive to Cell Death Induced by Exogenous Oxidative Stress
pp. 202-208(7)
Authors: Ari, Ferda; Sarimahmut, Mehmet; Ulukaya, Engin

Favourites:
ADD

Open Access Bladder Cancer and Stem Cells
pp. 209-219(11)
Authors: Drewa, Tomasz; Krzyzanowska, Sandra; Marszalek, Andrzej; Bajek, Anna

Favourites:
ADD

Open Access Myogenic Differentiation of Mesenchymal Stem Cells is Induced by Striated Muscle Influences in vitro
pp. 220-227(8)
Authors: Bajek, Anna; Drewa, Tomasz; Joachimiak, Romana; Spoz, Zaneta; Gagat, Maciej; Bodnar, Magdalena; Debski, Robert; Grzanka, Alina; Marszalek, Andrzej

Favourites:
ADD

Open Access Enhanced Free Radical Status of Cancer Cells Success and Failure of Prooxidant/Antioxidant Treatment
pp. 228-236(9)
Author: Afanas'ev, Igor

Favourites:
ADD

Open Access YB-1 Protein and Multidrug Resistance of Tumor Cells
pp. 237-246(10)
Authors: Stavrovskaya, Alla; Stromskaya, Tatyana; Rybalkina, Ekaterina; Moiseeva, Natalia; Vaiman, Andrey; Guryanov, Sergey; Ovchinnikov, Lev; Guens, Gelena

Favourites:
ADD

Open Access The Role of Ghrelin Signals in Breast Cancer- A Systematic Review
pp. 247-253(7)
Authors: Stefanaki, Charikleia; Rorris, Filippos-Paschalis; Stamatakos, Michael

Favourites:
ADD

Open Access Resistance to Radiotherapy and Targeted Molecular Therapies in Squamous Cell Carcinomas of the Head and Neck, Preclinical Data and New Approaches
pp. 254-264(11)
Author: Schottdorf, Eva-Maria

Favourites:
ADD

Open Access Tailored Angiogenesis Inhibition in Cancer Therapy: Respecting the Heart to Improve the Net Outcome
pp. 265-288(24)
Authors: Passerini, Jasmine; Romiti, Adriana; D'Antonio, Chiara; Mastromarino, Vittoria; Marchetti, Paolo; Volpe, Massimo; Conti, Elena

Favourites:
ADD

Open Access IP6 (Inositol Hexaphosphate) as a Signaling Molecule
pp. 289-304(16)
Authors: Kalam Shamsuddin, Abul; Bose, Sanchita

Favourites:
ADD

Open Access MicroRNAs and Pancreatic Cancer: Current Research and Future Outlooks
pp. 305-307(3)
Authors: Li, Wei; Satoh, Kei; G. LeBrun, Drake; Li, Min

Favourites:
ADD

Open Access ACKNOWLEDGMENT TO THE REVIEWERS
pp. 308-308(1)
Author: Bentham Science Publishers

Favourites:
ADD

Share Content

  • Access Key
  • Free content
  • Partial Free content
  • New content
  • Open access content
  • Partial Open access content
  • Subscribed content
  • Partial Subscribed content
  • Free trial content